Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ota Fuchs

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Plos One|May 21, 2015
Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid LeukemiaKateřina Kuželová, Barbora Brodská, Ota Fuchs, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4Ota Fuchs, Olga Simakova, Pavel Klener, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosisDana Grebenová, Katerina Kuzelová, Ota Fuchs, et al.
Leukemia Research|July 4, 2012
Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylationHana Hájková, Jana Marková, Cedrik Haškovec, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 14, 2003
Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cellsDana Grebenová, Katerina Kuzelová, Karel Smetana, et al.
Acta Haematologica|June 25, 2011
Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasiaPetr Lemež, Hana Klamová, Zuzana Zemanová, et al.
Leukemia Research|April 4, 2018
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)Anna Jonasova, Radana Neuwirtova, Helena Polackova, et al.
Plos One|December 18, 2018
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosminKateřina Kuželová, Barbora Brodská, Johannes Schetelig, et al.
Molecular Oncology|July 23, 2020
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromesMiroslav Pribyl, Sona Hubackova, Alena Moudra, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemiaIveta Sárová, Jana Brezinová, Zuzana Zemanová, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|May 21, 2015
Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid LeukemiaKateřina Kuželová, Barbora Brodská, Ota Fuchs, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4Ota Fuchs, Olga Simakova, Pavel Klener, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosisDana Grebenová, Katerina Kuzelová, Ota Fuchs, et al.
Leukemia Research|July 4, 2012
Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylationHana Hájková, Jana Marková, Cedrik Haškovec, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 14, 2003
Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cellsDana Grebenová, Katerina Kuzelová, Karel Smetana, et al.
Acta Haematologica|June 25, 2011
Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasiaPetr Lemež, Hana Klamová, Zuzana Zemanová, et al.
Leukemia Research|April 4, 2018
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)Anna Jonasova, Radana Neuwirtova, Helena Polackova, et al.
Plos One|December 18, 2018
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosminKateřina Kuželová, Barbora Brodská, Johannes Schetelig, et al.
Molecular Oncology|July 23, 2020
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromesMiroslav Pribyl, Sona Hubackova, Alena Moudra, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemiaIveta Sárová, Jana Brezinová, Zuzana Zemanová, et al.
Pageof 3